Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels

  • Ankit Dhiman
  • , Charles C. Vining
  • , Hunter D.D. Witmer
  • , Divya Sood
  • , Ardaman Shergill
  • , Hedy Kindler
  • , Kevin K. Roggin
  • , Mitchell C. Posner
  • , Osmanuddin S. Ahmed
  • , Stanley Liauw
  • , Sean Pitroda
  • , Chih Yi Liao
  • , Theodore Karrison
  • , Ralph Weichselbaum
  • , Blase Polite
  • , Oliver S. Eng
  • , Daniel V.T. Catenacci
  • , Kiran K. Turaga

Research output: Contribution to journal › Article › peer-review

9   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science